Prescribers and Naloxone Pharmacy Claims

Published in: Journal of General Internal Medicine, Volume 35, page 2475 (2020). doi: 10.1007/s11606-020-05791-5

Posted on RAND.org on April 13, 2021

by Rosanna Smart, Caroline Geiger, Christopher M. Jones, Bradley D. Stein

Read More

Access further information on this document at Journal of General Internal Medicine

This article was published outside of RAND. The full text of the article can be found at the link above.

We appreciate the response from Truong, Patil, and Rich to our study regarding retail pharmacy naloxone prescriptions and thank them for highlighting the importance of patient and caregiver education for individuals receiving naloxone. While naloxone is generally considered a safe medication, like almost all medications, there are risks of unintended adverse consequences if not used as intended. It is essential that prescribers educate patients and caregivers regarding the circumstances when naloxone should be administered, and the procedures for administering it, when writing a naloxone prescription. In addition, since nearly all states have laws or policies that allow individuals to obtain naloxone from a pharmacist without a prescription from a physician, pharmacists also play a critical role in counseling patients and caregivers regarding the circumstances when naloxone should be administered and proper procedures for administration.

Research conducted by

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.